Cardiovasc drugs ther. impact factor

Author: zdlh

August undefined, 2024

WebAlso covered are the detrimental effects of new cardiovascular drugs, and cardiovascular effects of non-cardiovascular drugs, anti-cancer chemotherapy, and gene therapy. ... Year: Impact Factor (IF) Total Articles: Total Cites: 2024 (2024 update) 2.755-1938: 2024: 3.231: 86: 1772: 2024: 2.284: 58: 1272: ... Cardiovasc Ther Prev. Cardiovascular ... WebMay 27, 2024 · The impact score (IS) 2024 of Cardiovascular Drugs and Therapy is 3.33, which is computed in 2024 as per its definition.Cardiovascular Drugs and Therapy IS is …

Real-world Comparisons of Direct Oral Anticoagulants for Stroke ...

WebMay 27, 2024 · The impact score (IS) 2024 of Therapeutic Advances in Cardiovascular Disease is 3.03, which is computed in 2024 as per its definition.Therapeutic Advances in … WebJan 25, 2024 · Hypertriglyceridemia has been identified as a risk factor for cardiovascular disease and acute pancreatitis. To date, there are only few drug classes targeting triglyceride levels such as fibrates and ω-3 fatty acids. These agents are at times insufficient to address very high triglycerides and the residual cardiovascular risk in … redcliffe district sport

Journal of Cardiovascular Pharmacology - SCImago Journal Rank

WebApr 14, 2024 · A small natural substance called cirsilineol (CSL), which was discovered in the plant Artemisia vestita, is lethal to many cancer cells and has antioxidant, anticancer, and antibacterial properties. Here, we investigated the underlying mechanisms of the antithrombotic action of CSL. We demonstrated that CSL has antithrombotic efficacy … WebCardiovascular Therapeutics publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of novel cardiovascular … WebJACC: Heart Failure is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC).It publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical … knowledge success toshiko kaneda

Cardiovascular Drugs and Therapy Home

WebCirc Cardiovasc Qual Outcomes. 2009;2(6):607–615. 27. Zeller T, Krankenberg H, Steinkamp H, et al. One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther. 2009;16(6):653–662. 28. WebScope. Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke ... knowledge success blogWebMay 5, 2024 · Finally, there is emerging evidence about new translational drugs on the microcirculation (including growth factors and non-coding RNA therapeutics, as well as the targeting of metabolites or metabolic signaling) . Forthcoming trials would better assess coronary microcirculation by cardiac magnetic resonance imaging (cMRI) (33, 34). … knowledge studio software

"" - Cardiovasc drugs ther. impact factor

Cardiovasc drugs ther. impact factor

Therapeutic Advances in Cardiovascular Disease - Impact Factor, …

WebCardiovasc Drugs Ther. 2024 Jun;36(3):511-524. doi: 10.1007/s10557-021-07181-3. ... Nevertheless, drugs targeting human epidermal growth factor receptor 2 (HER-2), angiogenesis, and other tyrosine kinases also come with unexpected cardiac side effects, including heart failure, hypertension, arterial thrombosis, and arrhythmias, and have ... WebApr 4, 2024 · Cardiovascular Drugs and Therapy is a careful and accurate guide for clinicians and researchers to navigate new products and therapies in cardiovascular pharmacology that will remain an essential and timeless resource. ... Impact factor … Volumes and issues. Volume 37 February - April 2024. April 2024, issue 2; February …

Did you know?

WebApr 6, 2024 · Expert Review of Cardiovascular Therapy. Publish open access in this journal. Medline-indexed journal on therapeutic cardiology, focusing on heart disease, vascular … WebBackground: Whether four direct oral anticoagulants (DOACs) are superior to warfarin among Asians with non-valvular atrial fibrillation (NVAF) remains unclear in the real-world setting. Methods: We searched PubMed and Medline + Journals@Ovid + EMBASE from September 17, 2009 to May 4, 2024 to perform a systematic review and meta-analysis of …

WebThere are many factors influencing the treatment adherence of hypertensive patients. The aim of this study was to examine the effect of social support on the treatment adherence in hypertension in China. ... (r=0.568) had greater impact on treatment adherence than that from kinship (r=0.364) and nuclear family (r=0.262). ... Cardiovasc Drugs ... WebThe Cardiovascular Drugs and Therapy Latest Journal's Impact IF 2024-2024 is 3.947. More Cardiovascular Drugs and Therapy Journal's Impact Trend, Prediction, Ranking & Key Factor Analysis are all in Acadmeic Accelerator.

WebHoming in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic … WebCardiovascular Research is the international journal of the European Society of Cardiology for basic and translational research, spanning all topics within cardiology and cardiovascular biology. The journal aims to enhance insight into cardiovascular disease mechanisms and the prospects for innovation. The journal welcomes submission of papers ...

WebMar 30, 2024 · Impact Factor: 2.807 / 5-Year Impact Factor: 2.895 . JOURNAL HOMEPAGE. SUBMIT PAPER. Journal of Cardiovascular Pharmacology and …

WebCardiovasc is a medicine available in a number of countries worldwide. A list of US medications equivalent to Cardiovasc is available on the Drugs.com website. ... redcliffe dolphins drawWebApr 6, 2024 · Disclosure: 1.The series “Endovascular and Surgical Interventions in the End Stage Renal Disease Population” was commissioned by the editorial office, … knowledge structures bernstein 2000WebImpact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation Cardiovasc Drugs Ther. 2024 Oct;33(5):615-623. doi: 10.1007/s10557-019-06907-8. ... Risk Factors Stroke / diagnosis ... knowledge substance abuse online courseWebMay 27, 2024 · The impact score (IS) 2024 of Therapeutic Advances in Chronic Disease is 4.49, which is computed in 2024 as per its definition.Therapeutic Advances in Chronic Disease IS is increased by a factor of 0.05 and approximate percentage change is 1.13% when compared to preceding year 2024, which shows a rising trend. The impact score … redcliffe dolphins gamesWebCardiovasc Drugs Ther. 2016;30:539–550. 35. Birnbaum GD, Birnbaum I, Ye Y, Birnbaum Y. Statin-induced cardioprotection against ischemia-reperfusion injury: potential drug–drug interactions. Lesson to be learnt by translating results from animal models to the clinical settings. Cardiovasc Drugs Ther. 2015;29:461–467. 36. redcliffe dolphins jobWebInitial statin dose after myocardial infarction and long-term cardiovascular outcomes. Aims Effective statin therapy is a cornerstone of secondary prevention after myocardial infarction (MI). Real-life statin dosing is nevertheless suboptimal and largely determined early after MI. We studied long-term outcome impact of initial statin dose after MI. redcliffe dolphins news and rumorsWebHypertension in the US Black population: risk factors, complications, and potential impact of central aortic pressure on effective treatment Cardiovasc Drugs Ther . 2012 … knowledge success